Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_assertion type Assertion NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_head.
- NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_assertion description "[The two genes of the GAGE family that code for this peptide, namely GAGE-1 and GAGE-2, are expressed in a significant proportion of melanomas (24%), sarcomas (25%), non-small cell lung cancers (19%), head and neck tumors (19%), and bladder tumors (12%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_provenance.
- NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_assertion evidence source_evidence_literature NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_provenance.
- NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_assertion SIO_000772 7544395 NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_provenance.
- NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_assertion wasDerivedFrom befree-2016 NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_provenance.
- NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_assertion wasGeneratedBy ECO_0000203 NP1311853.RAwfEgLraMEjJKkrVXukAIruYl3deavSUJhg9RjAQdFN4130_provenance.